Hasim, Ibrahim E.

HRN: 28-69-92  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/18/2026
03/25/2026
IVT
2.25g
Q6
CAP HR
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines